Visceral fat and beta cell function in non-diabetic humans

Diabetologia

Volumn 48, Issue 10, 2005, Pages 2090-2096

  Gastaldelli, A ^a   Sironi, A M ^a   Ciociaro, D ^a   Positano, V ^a   Buzzigoli, E ^a   Giannessi, D ^a   Lombardi, M ^a   Mari, A ^b   Ferrannini, E ^a,c  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Human; Imaging; Insulin secretion in vivo; Insulin sensitivity and resistance; Metabolic physiology in vivo; Metabolic syndrome; MRI; Pathophysiology metabolism; Prediction and prevention of type 2 diabetes; Weight regulation and obesity

Indexed keywords

AMINOTRANSFERASE; C PEPTIDE; GLUCOSE; INSULIN;

ADIPOSE TISSUE; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; VISCERA;

EID: 26244453122     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1891-3     Document Type: Article

References (28)

1. Despres JP (1998) The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk. Obes Res 16 (Suppl 1):8S-17S
2. Goodpaster BH, Krishnaswami S, Resnick H et al (2003) Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 26:372-379
3. Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3-19
4. Ferrannini E, Camastra S, Gastaldelli A et al (2004) Beta-cell function in obesity: effects of weight loss. Diabetes 53(Suppl 3):S26-S33
5. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, De Fronzo RA (2005) Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90:493-500
6. Ferrannini E, Gastaldelli A, Miyazaki Y et al (2003) Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 46:1211-1219
7. Kohrt WM, Kirwan JP, Staten MA, Bourey RE, King DS, Holloszy JO (1993) Insulin resistance in aging is related to abdominal obesity. Diabetes 42:273-281
8. Iozzo P, Beck-Nielsen H, Laakso M, Smith U, Yki-Jarvinen H, Ferrannini E (1999) Independent influence of age on basal insulin secretion in nondiabetic humans. European group for the study of insulin resistance. J Clin Endocrinol Metab 84:863-868
9. Goran MI, Bergman RN, Gower BA (2001) Influence of total vs. visceral fat on insulin action and secretion in African American and white children. Obes Res 9:423-431
10. Sumner AE, Farmer NM, Cochran CS et al (2001) Obese premenopausal African-American women with normal and impaired glucose tolerance have a similar degree of insulin resistance but differ in beta-cell function. Diabetes Care 24:1978-1983
11. Cruz ML, Bergman RN, Goran MI (2002) Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care 25:1631-1636
12. Wagenknecht LE, Langefeld CD, Scherzinger AL et al (2003) Insulin sensitivity, insulin secretion, and abdominal fat. The Insulin Resistance Atherosclerosis Study (IRAS) family study. Diabetes 52:2490-2496
13. Utzschneider KM, Carr DB, Hull RL et al (2004) Impact of intra-abdominal fat and age on insulin sensitivity and beta-cell function. Diabetes 53:2867-2872
14. Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377
15. Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159-E1166
16. Gabir MM, Hanson RL, Dabelea D et al (2000) The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23:1108-1112
17. Ross R, Leger L, Morris D, de Guise J, Guardo R (1992) Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 72:787-795
18. Positano V, Gastaldelli A, Sironi AM, Santarelli MF, Lombardi M, Landini L (2004) An accurate and robust method for unsupervised assessment of abdominal fat by MRI. J Magn Reson Imaging 20:684-689
19. Snyder W, Cooke M, Mnassett E, Larhansen L, Howells G, Tipton I (1975) Report of the task group on reference man. Pergamon Press, Oxford
20. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539-548
21. Kobayashi J, Tadokoro N, Watanabe M, Shinomiya M (2002) A novel method of measuring intra-abdominal fat volume using helical computed tomography. Int J Obes Relat Metab Disord 26:398-402
22. Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697-738
23. Ferrannini E, Mari A (2004) Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 47:943-956
24. Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3-19
25. Robertson RP, Harmon J, Tran PO, Poitout V (2004) Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53(Suppl 1):S119-S124
26. Wajchenberg BL, Giannella-Neto D, Da Silva ME, Santos RF (2002) Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 34:616-621
27. Kabir M, Catalano KJ, Ananthnarayan S et al (2005) Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 288:E454-E461
28. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD (2004) Splanchnic lipolysis in human obesity. J Clin Invest 113:1582-1588